When the CNV levels were applied for patient grouping on TIDE, high JMJD8 CNV group patients showed higher survival rates in AML, KIRC, COADREAD, and LIHC but lower survival rates in UCEC, BRCA (HER2), HNSC (HPV+), and PADD (Figure 3C). Here, ERBB2 is linked to acute myeloid leukemia.